18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC
NCT03564197
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
NSCLC Stage IV
Interventions
OTHER:
18F-PD-L1
Sponsor
The Netherlands Cancer Institute
Collaborators
[object Object]